Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis

Fig. 5

Forest plot and pooled HR and 95% CI for OS in patients with NSCLC: pretreatment decreased Hb vs. normal Hb. The pooled HR for OS indicated that pretreatment decreased Hb level had a negative impact on survival of patients with NSCLC both in early stage and advanced stage. NSCLC non-small cell lung cancer, HR hazard ratios, OS overall survival, CI confidence interval, Hb hemoglobin

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us